| Code | 3390C | ||||||||||
| MA number | 09/0084/17-S | ||||||||||
| Product Form: | cps end 28x20 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 18 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.03.2017 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Omemyl 20 mg_cps end_04 2023.pdf
|
| PIL: |
PIL_Omemyl 20 mg_cps end_04 2023.pdf
|
| Safety feature | Yes |
| Data update: | 14.11.2019 |
